Krystexxa 8MG
Ended Awarded
- Contract number
- 36C24524N0291
- Awardee
-
Horizon Therapeutics Usa, Inc. UEI SK1UK7S74GB3
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $55,903
Award facts
- Contract value 100% obligated
- $55,903.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- La Vergne, TN 37086, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order for $55,903.32 was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 to Horizon Therapeutics USA Inc. against the company's Multiple Award Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). The firm fixed price order, with no set-aside designation, is for the medication KRYSTEXXA 8MG and aims to supply VHA hospitals and clinics in La Vergne, Tennessee with this orphan disease treatment through January 2024 to support healthcare services for veterans. Horizon Therapeutics holds an additional $18 million Blanket Purchase Agreement against the same Pharmaceuticals and Drugs Schedule, allowing the VA to order Ravicti, Buphenyl, Krystexxa, Procysbi and Actimmune through September 2024 for delivery to VA Medical Centers and regional networks nationwide.
Quick answers
Who was awarded contract 36C24524N0291?
36C24524N0291 was awarded to Horizon Therapeutics Usa, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on January 26, 2024.
How much is contract 36C24524N0291 worth?
The government has obligated $55,903 on 36C24524N0291.
Is contract 36C24524N0291 an order under another contract?
Yes. 36C24524N0291 is a delivery order under 36F79719D0224, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24524N0291 competed?
The extent of competition for 36C24524N0291 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award